Procaps S. A., a business company, incorporated and existing under the laws of Colombia, with main domicile in the city of de Barranquilla, Colombia, identified with TIN 802.009.120 – 6, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, as evidenced in the certificate of existence and legal representation issued by the Chamber of Commerce de Barranquilla and in the copy of Minutes No. 176 dated November 9, 2018 of the Board of Directors, enclosed as Exhibit B hereof (“C.I. Procaps”);
Procaps S. A. PROCAPS GROUP, S.A.
Procaps S. A. a sociedad anónima, incorporated and existing under the laws of Colombia, with its principal place of business in the city of Barranquilla, Colombia, identified with NIT 802.009.120 – 6, represented by the person signing this Agreement in its behalf, who acts with sufficient powers and authority to enter into this Agreement, as evidenced by the certificate of existence and legal representation issued by the Chamber of Commerce of Barranquilla (Cámara de Comercio de Baranquilla) and the corporate authorizations attached as Schedule C to this Agreement (“C.I. Procaps”);
Procaps S. A. Colombia Inversiones Ganeden SAS Inversiones Jades SAS Industrias Kadima SAS Inversiones Crynseen SAS Inversiones Xxxxx SAS 9.98% 9.98% 9.98% 22.4% 47.64%
Procaps S. A. (“Procaps”) is interested in taking an exclusive Collaboration, Supply, Marketing and Distribution Agreement (hereinafter “the Agreement”) for the PRODUCT used for the treatment of cancer in the TERRITORY.
Procaps S. A. de C.V. a sociedad anónima de capital variable, incorporated and existing under the laws of El Salvador, identified with tax identification number 0614-280878 – 003 – 7, represented by the person signing this Agreement in its behalf, who acts with sufficient powers and authority to enter into this Agreement, as evidenced by the corporate authorizations attached as Schedule F to this Agreement (“Procaps (El Salvador)“and, jointly with C.I. Procaps, Diabetrics, and Funtrition, the “Original Subsidiary Guarantors”);
Procaps S. A., a business company incorporated and existing under the laws of Colombia, domiciled in the city of Barranquilla, Colombia, identified with TIN 802.009.120- 6, represented by the individual executing this Agreement on its behalf, represented by the individual executing this Agreement on its behalf, who acts with the sufficient powers and authority to do so, as recorded in the certificate of existence and legal representation issued by the Barranquilla Chamber of Commerce and copy of Minutes No. 176 of November 9, 2018 of the Board of Directors, enclosed hereto as Exhibit B (“C.I. Procaps”);
Procaps S. A., a sociedad anónima organized under the laws of Colombia
Procaps S. A., a sociedad anónima organized under the laws of Colombia Diabetrics Healthcare S.A.S., a sociedad por acciones simplificada organized under the laws of Colombia Pharmayect S.A., a sociedad por acciones simplificada organized under the laws of Colombia Procaps, S.A. de C.V., a sociedad anónima de capital variable organized under the laws of El Salvador Biokemical, S.A. de C.V., a sociedad anónima de capital variable organized under the laws of El Salvador Colbras Indústria e Comércio Ltda., a sociedade limitada organized under the laws of Brazil, enrolled with the Brazilian Taxpayer’s Registry (CNPJ) under nº 00.413.925/0001-64 Sofgen Pharmaceuticals LLC, a limited liability company organized under the laws of the State of Florida Crynssen Pharma Group Ltd, a private limited liability company registered and organized under the laws of Malta under company registration number C 59671
Procaps S. By: /s/ Xxxxxxx Xxxxxx Xxxxxx Name: Xxxxxxx Xxxxxx Xxxxxx Title: Legal Representative By: /s/ Xxxxxxx Xxxxxx Xxxxxx Name: Xxxxxxx Xxxxxx Xxxxxx Title: Authorized Representative
